Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $6,117 | 9 | 39.8% |
| Food and Beverage | $5,786 | 283 | 37.7% |
| Travel and Lodging | $3,451 | 19 | 22.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| INTUITIVE SURGICAL, INC. | $8,056 | 21 | $0 (2024) |
| Veran Medical Technologies, Inc. | $981.80 | 6 | $0 (2019) |
| Olympus Corporation of the Americas | $851.03 | 7 | $0 (2022) |
| GlaxoSmithKline, LLC. | $680.71 | 40 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $603.43 | 38 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $562.64 | 26 | $0 (2023) |
| Insmed, Inc. | $416.64 | 17 | $0 (2024) |
| Ethicon Inc. | $277.54 | 2 | $0 (2020) |
| United Therapeutics Corporation | $252.86 | 5 | $0 (2022) |
| GENZYME CORPORATION | $226.80 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $763.97 | 34 | GENZYME CORPORATION ($135.85) |
| 2023 | $7,311 | 53 | Intuitive Surgical, Inc. ($6,494) |
| 2022 | $3,091 | 75 | Intuitive Surgical, Inc. ($932.69) |
| 2021 | $487.43 | 25 | United Therapeutics Corporation ($130.07) |
| 2020 | $1,143 | 20 | Intuitive Surgical, Inc. ($613.03) |
| 2019 | $1,482 | 37 | Veran Medical Technologies, Inc. ($970.16) |
| 2018 | $628.83 | 38 | Boehringer Ingelheim Pharmaceuticals, Inc. ($154.86) |
| 2017 | $446.54 | 29 | GlaxoSmithKline, LLC. ($100.83) |
All Payment Transactions
311 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $27.00 | General |
| Category: RESPIRATORY | ||||||
| 12/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $32.73 | General |
| Category: Respiratory | ||||||
| 12/03/2024 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 12/02/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $41.33 | General |
| Category: Immunology | ||||||
| 10/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: IMMUNOLOGY | ||||||
| 10/07/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $34.92 | General |
| Category: Immunology | ||||||
| 10/02/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.89 | General |
| Category: Immunology | ||||||
| 09/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $28.94 | General |
| Category: RESPIRATORY | ||||||
| 09/06/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: IMMUNOLOGY | ||||||
| 09/05/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 08/22/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $32.20 | General |
| Category: General - Therapies_ENDO | ||||||
| 08/21/2024 | Pulmonx Corporation | ZEPHYR ENDOBRONCHIAL VALVE (Device) | Food and Beverage | Cash or cash equivalent | $38.00 | General |
| Category: PULMONOLOGY | ||||||
| 08/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: RESPIRATORY | ||||||
| 08/16/2024 | ABBVIE INC. | AVYCAZ (Drug), TEFLARO | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/15/2024 | Olympus America Inc. | Spiration Valve System (Device) | Food and Beverage | In-kind items and services | $58.08 | General |
| Category: Endotherapy | ||||||
| 07/22/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: IMMUNOLOGY | ||||||
| 07/19/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $17.01 | General |
| Category: Narcoplepsy | ||||||
| 07/17/2024 | ABBVIE INC. | AVYCAZ (Drug), TEFLARO | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/19/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Respiratory | ||||||
| 06/10/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 06/06/2024 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $22.82 | General |
| Category: Allergy/Immunology | ||||||
| 05/06/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 04/30/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $10.31 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,387 | 1,886 | $697,422 | $192,333 |
| 2022 | 21 | 1,095 | 1,566 | $574,578 | $149,883 |
| 2021 | 26 | 1,534 | 1,905 | $597,923 | $168,109 |
| 2020 | 25 | 1,104 | 1,600 | $566,693 | $153,740 |
All Medicare Procedures & Services
94 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 442 | 744 | $194,184 | $70,135 | 36.1% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 51 | 51 | $127,500 | $26,077 | 20.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 107 | 215 | $48,375 | $20,440 | 42.3% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2023 | 33 | 33 | $75,240 | $16,123 | 21.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 104 | 104 | $38,480 | $12,463 | 32.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 13 | 42 | $20,160 | $7,211 | 35.8% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Office | 2023 | 43 | 48 | $31,392 | $5,684 | 18.1% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 107 | 108 | $20,628 | $4,404 | 21.3% |
| 31653 | Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 3 or more lymph nodes | Facility | 2023 | 22 | 23 | $17,434 | $4,365 | 25.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 45 | 63 | $9,765 | $4,041 | 41.4% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 90 | 90 | $15,300 | $3,723 | 24.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 35 | 35 | $10,290 | $3,665 | 35.6% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 108 | 109 | $21,037 | $3,310 | 15.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 23 | 23 | $10,005 | $3,209 | 32.1% |
| 31628 | Biopsy of lobe of lung using an endoscope, 1 lobe | Facility | 2023 | 30 | 30 | $16,440 | $2,487 | 15.1% |
| 31629 | Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | Facility | 2023 | 16 | 16 | $9,248 | $1,551 | 16.8% |
| 31627 | Computer-assisted image-guided navigation of lung airways using an endoscope | Facility | 2023 | 20 | 20 | $6,980 | $1,524 | 21.8% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 16 | 39 | $2,535 | $674.64 | 26.6% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 19 | 19 | $3,211 | $670.70 | 20.9% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 40 | 40 | $17,800 | $311.23 | 1.7% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2023 | 11 | 11 | $682.00 | $167.09 | 24.5% |
| 85610 | Blood test, clotting time | Office | 2023 | 12 | 23 | $736.00 | $96.60 | 13.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 393 | 712 | $185,832 | $64,315 | 34.6% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2022 | 41 | 41 | $93,220 | $18,961 | 20.3% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2022 | 36 | 36 | $90,000 | $18,594 | 20.7% |
About Dr. Prasad Garimella, MD
Dr. Prasad Garimella, MD is a Pulmonary Disease healthcare provider based in Braselton, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1770568792.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Prasad Garimella, MD has received a total of $15,354 in payments from pharmaceutical and medical device companies, with $763.97 received in 2024. These payments were reported across 311 transactions from 48 companies. The most common payment nature is "Education" ($6,117).
As a Medicare-enrolled provider, Garimella has provided services to 5,120 Medicare beneficiaries, totaling 6,957 services with total Medicare billing of $664,065. Data is available for 4 years (2020–2023), covering 94 distinct procedure/service records.
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Sleep Medicine, Critical Care Medicine
- Location Braselton, GA
- Active Since 12/13/2005
- Last Updated 10/15/2020
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1770568792
Products in Payments
- Da Vinci Surgical System (Device) $8,056
- Spin (Device) $981.80
- Single Use Guide Sheath Kit (Device) $851.03
- Arikayce (Drug) $416.64
- TRELEGY ELLIPTA (Drug) $365.40
- OFEV (Drug) $341.78
- TEZSPIRE (Biological) $335.01
- DUPIXENT (Biological) $326.82
- ACTHAR (Biological) $288.46
- Monarch Platform (Device) $277.54
- TYVASO (Drug) $222.29
- NUCALA (Biological) $161.62
- SYMBICORT (Drug) $142.31
- GLASSIA (Biological) $111.64
- Prolastin-C (Biological) $104.73
- Prolastin-C Liquid (Biological) $98.36
- XOLAIR (Biological) $89.53
- BREZTRI (Drug) $82.04
- YUPELRI (Drug) $78.98
- OPSUMIT (Drug) $71.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.